Response to treatment in NMOSD: the Australasian experience
Background: Neuromyelitis optica spectrum disorder (NMOSD) is associated with significant morbidity and mortality. Several therapies have been recommended for NMOSD and more recently clinical trials have demonstrated efficacy for three monoclonal ...
Clarke, L. +26 more
core
Xiaotong Li,1– 3,* Wencan Jiang,1– 3,* Guoge Li,1– 3 Yaowei Ding,1– 3 Haoran Li,1– 3 Jialu Sun,1– 3 Yuxin Chen,1– 3 Siqi Wang,1– 3 Guojun Zhang1– 3 1Department of Clinical Diagnosis, Laboratory of Beijing Tiantan Hospital, Capital Medical ...
Li X +8 more
doaj
Apheresis therapies for NMOSD attacks
\(\bf Objective\) To analyze whether 1 of the 2 apheresis techniques, therapeutic plasma exchange (PE) or immunoadsorption (IA), is superior in treating neuromyelitis optica spectrum disorder (NMOSD) attacks and to identify predictive factors for complete remission (CR).
Kleiter, Ingo Wolfram (Prof. Dr. med.) +38 more
openaire +1 more source
Serum GFAP and Age Accurately Distinguish AQP4-IgG Positive and Double Seronegative NMOSD From MOGAD After a Recent Attack. [PDF]
Rival M +40 more
europepmc +1 more source
Background Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) can share similar features, posing diagnostic challenges.
Adamou, Antonis +14 more
core +1 more source
Soluble TIM-3 and galectin-9 in cerebrospinal fluid are associated with disability at 6 months in aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder. [PDF]
Nishii S +7 more
europepmc +1 more source
Characteristics of serum Metrnl levels in patients with neuromyelitis optica spectrum disorder and their associations with disease activity and inflammatory biomarkers. [PDF]
Li LM, Shao Y, Cai H, Yang L.
europepmc +1 more source
NMOSD and MOGAD Dual Positivity
Ayush Agarwal +5 more
openaire +3 more sources
Astrocytic and Axonal Injury Biomarkers in AQP4 Antibody-Positive NMOSD: Insights From PREVENT and CHAMPION-NMOSD. [PDF]
Wingerchuk DM +14 more
europepmc +1 more source
Plasmapheresis for NMOSD: Not a rescue therapy anymore!?
Rohit Bhatia +2 more
openaire +3 more sources

